|SEQ_NO||1||Date of announcement||2020/04/14||Time of announcement||19:06:54|
|Subject||Announcement of TTY Biopharm's unaudited income information in March 2020|
|Date of events||2020/4/14||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/04/14
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $412,723 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $122,477 thousands, and a consolidated income before tax of $136,802 thousands in Mar 2020; net income attributed to stockholders of the company was $108,074 thousands; EPS is $0.43.
Year-to-date consolidated net sales was $1,098,487 thousands (in NT dollars; unaudited), a consolidated operating profit was $285,672 thousands and consolidated income before tax was $327,139 thousands until Mar 2020; year-to-date net income attributed to stockholders of the company was $256,247 thousands; EPS is $1.03.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.